Virotek Biosciences Becomes Canada’s First Commercial Lab to Deploy AVITI24™ for Translational Genomics Research
MARKHAM, ONTARIO, CANADA, October 22, 2025 /EINPresswire.com/ — Virotek Biosciences Inc., a leading Canadian genomic company, today announced the installation and commissioning of the AVITI24™ 5D multi-omic system from Element Biosciences Inc., marking the first commercial deployment of this first-of-its-kind multi-omics platform in Canada. The AVITI24 system delivers exceptional sequencing throughput, accuracy, and cost efficiency, ...
Read More